Previous 10 | Next 10 |
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2022 financial results after the market close on Monday, October 24, 2022. The Company will host a conference call the following morning, Tuesday, October 25, 2022, at 9...
We are value investors - business analysts with a long-term time horizon focused on purchasing publicly traded companies that are competitively entrenched at significant discounts to intrinsic worth. All five of our strategies trailed their respective benchmarks during the quarter. ...
Medpace delivered a robust set of Q2 earnings with upsides on revenue and operating income. The company printed above-average FCF conversion and continues to deliver on long-term capital management trends. Return on investment / capital continues to compound higher and is well abo...
Image source: The Motley Fool. Medpace Holdings, Inc. Common Stock (NASDAQ: MEDP) Q2 2022 Earnings Call Jul 26, 2022 , 9:00 a.m. ET Operator Continue reading For further details see: Medpace Holdings, Inc. Common Stock (MEDP) Q2 2022 Earn...
Medpace Holdings, Inc. (MEDP) Q2 2022 Earnings Conference Call July 26, 2022 9:00 a.m. ET Company Participants Lauren Morris - Director of Investor Relations August Troendle - Chief Executive Officer Jesse Geiger - President Kevin Brady - Chief Financial Offi...
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Medpace Holdings, Inc. 2022 Q2 - Results - Earnings Call Presentation
Medpace Holdings ( NASDAQ: MEDP ) is projecting 2022 revenue of $1.405B-$1.435B, above the current consensus of $1.4B. The contract research organization is also guiding to GAAP EPS for the year of $6.07-$6.36. Consensus is $6.12. Medpace ( MEDP ) released its...
Medpace press release ( NASDAQ: MEDP ): Q2 GAAP EPS of $1.46 beats by $0.15 . Revenue of $351.21M (+26.2% Y/Y) beats by $7.2M . For further details see: Medpace GAAP EPS of $1.46 beats by $0.15, revenue of $351.21M beats by $7.2M
Revenue of $351.2 million in the second quarter of 2022 increased 26.2% from revenue of $278.3 million for the comparable prior-year period, representing a backlog conversion rate of 16.8%. Net new business awards were $450.6 million in the second quarter of 2022, representi...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2022 financial results after the market close on Monday, July 25, 2022. The Company will host a conference call the following morning, Tuesday, July 26, 2022, at 9:00 a...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...